FAST Congress  

Cambridge Healthtech Institute’s Inaugural
Lab Automation for 3-D Cell Culture
Achieving Higher-Throughput Screening
Part of the Inaugural FAST: Functional Analysis & Screening Technologies Congress

October 29-30, 2013 | Le Méridien Cambridge-MIT | Cambridge, MA

The paradigm shift from 2-D to 3-D cell culture models is underway and progressing rapidly. Although the screening community recognizes the functionality that 3-D models can provide, their implementation in any high-throughput screening laboratory is hampered by the lack of appropriate automation tools and technologies. In addition, when using complex models, the costs and read-out speed have to be taken into account. Cambridge Healthtech Institute’s Inaugural Lab Automation for 3-D Cell Culture: Achieving Higher-Throughput Screening convenes HTS laboratory managers, automation architects, LIMS specialists, cell culture scientists, robotic systems designers, and instrumentation engineers to advance the laboratory science and technology to move drug discovery into a new 3-D dimension.

Topics to be addressed with an emphasis on screening technologies for oncology, toxicology, and neuroscience:

Cell Source Considerations

  • Stem Cells
  • Cell Lines vs. Primary Cultures
  • Co-Culture
  • Organotypic Models

Analytical Techniques

  • HCA within 3-D
  • Reporter Genes
  • Fluorescence Optics
  • Luminescent and Fluorescent Signals
  • Multiplex Measurements
  • Image Data Analysis

3-D Systems

  • Static
  • Perfusion
  • Bioreactors

Lab Automation

  • Robotics
  • Liquid Handling


Engineers working with the technical developments driving this field, biological researchers developing models, or drug screening developers utilizing 3-D models are encouraged to submit a title and summary of their research for consideration of presentation.

Deadline for priority consideration is May 3, 2013.

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference is given to abstracts from those within pharmaceutical and biomedical companies, regulators, and those from academic research centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

To submit a proposal for consideration, please click here.

For questions or suggestions about the meeting, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781-972-5497

For sponsorship and exhibit sales information, please contact:
Ilana Quigley
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5457